“The negative outlook reflects our view of Milford’s weakened financial profile in fiscal 2016 and some uncertainty about its ability to achieve its projections for fiscal 2017,” said S&P analyst Jennifer Soule.
S&P also affirmed the “BBB-” rating on Milford’s bonds.
More articles on healthcare finance:
Fitch revises Cullman Regional Medical Center’s outlook to stable
Black Book ranks Nuance No. 1 end-to-end CDI vendor
CVS to lose 40M prescriptions as payers narrow networks
